A Series of Primary Signet Ring Cell Carcinoma of the Urinary Bladder

被引：1

作者：

Nerli Rajendra B. ^{[1
]}

Pingale N.D. ^{[1
]}

Ghagane S.C. ^{[2
]}

Wagh A.T. ^{[1
]}

Malur P.R. ^{[3
]}

机构：

[1] Department of Urology, KLES Kidney Foundation, KLES Dr. Prabhakar Kore Hospital & M.R.C, Nehru Nagar, Belagavi, 590010, Karnataka

[2] Department of Biotechnology and Microbiology, Karnatak University, Dharwad, Karnataka

[3] Department of Pathology, KLES Dr. Prabhakar Kore Hospital & M.R.C, Nehru Nagar, Belagavi, 590010, Karnataka

来源：

Indian Journal of Surgical Oncology | 2017年 / 8卷 / 3期

关键词：

Adenocarcinoma; Carcinoma; Signet ring cell; Urinary bladder;

D O I：

10.1007/s13193-017-0664-z

中图分类号：

学科分类号：

摘要：

Primary signet ring cell carcinomas of the bladder (PSRCCB) are extremely rare tumors. These tumors generally present as high-grade, high-stage tumors and have a uniformly poor prognosis. PSRCCB need to be differentiated from metastases from other primary sites. Clinical, imaging, and immune-histochemical findings may help in identifying the primary source of signet cell cancer. We retrospectively reviewed our series of patient identified to have primary signet cell carcinoma of the bladder. We retrospectively reviewed all case records of patients with carcinoma bladder. Only patients with a histopathological report of signet ring cell carcinoma of the bladder were included in this study. During the period Sept 1991 to Aug 2016, a total five patients (0.18%) were diagnosed to have had PSRCCB. Hematuria was the main symptom in four of the five patients. Cystoscopy/TURBT was done in all patients, and histological examination confirmed signet cell carcinoma. All the patients were counseled and underwent radical cystectomy. The mean overall survival was 28.2 ± 3.7 months. We report a small series of primary signet cell carcinoma presenting over a 25-year period with an overall incidence of 0.18%. Post radical cystectomy local recurrence/distant metastases are common and response to chemotherapy was poor. The overall outcome for signet-ring cell cancers in general is very poor. © 2017, Indian Association of Surgical Oncology.

引用

页码：443 / 446

页数：3

共 13 条

[1]

Wood D.P., Tumors of the bladder, Campbell Walsh urology, (2016)

[2]

Guntaka A.K., Nerli R.B., Malur P.R., Hiremath M.B., Primary signet ring cell carcinoma of the urinary bladder—a case report, Int J Rec Sci Res, 5, pp. 861-862, (2014)

[3]

Thomas D.G., Ward A.M., Williams J.L., A study of 52 cases of adenocarcinoma of the bladder, Br J Urol, 43, pp. 4-15, (1971)

[4]

Michels J., Barbour S., Cavers D., Chi K.N., Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature, Can Urol Assoc J, 4, pp. E55-E57, (2010)

[5]

Ozeki Z., Kobayashi S., Machida T., Et al., Transitional cell carcinoma of the urinary bladder accompanied by signet-ring cell carcinoma: a case report [in Japanese], Hinyokika Kiyo, 49, pp. 411-413, (2003)

[6]

Saphir O., Signet-ring cell carcinoma of the urinary bladder, Am J Pathol, 31, pp. 223-231, (1955)

[7]

Parkin D.M., The global burden of urinary bladder cancer, Scand J Urol Nephrol, 42, pp. 12-20, (2008)

[8]

Romics I., Sze'kely E., Szendroi A., Signet-ring cell carcinoma arising from the urinary bladder, Canadian Journal of Urology, 15, pp. 4266-4268, (2008)

[9]

Akamatsu S., Takahashi A., Ito M., Ogura K., Primary signet-ring cell carcinoma of the urinary bladder, Urology, 75, pp. 615-618, (2010)

[10]

Fiter L., Gimeno F., Martin L., Gomez T.L., Signet-ring cell adenocarcinoma of bladder, Urology, 41, pp. 30-33, (1993)

← 1 2 →